StreetAlpha.app
Home › Stocks › SYK

Stryker Corp (SYK)

Healthcare
$317.60
▲ +2.23%
LAST CLOSE · NOV 17

Stryker makes surgical, orthopaedic and emergency medical products sold mainly to doctors and hospitals. It last closed at $317.60 on Nov 17, up 2.23% on the day. SYK reports earnings on Thu, Feb 4, 2027. The average 12-month price target from 14 analysts is $334.71 (+5.4% from the last close), with a high of $390.00 and a low of $290.00. Analyst consensus is Strong Buy, based on the latest ratings from 14 firms (11 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 8 whale options trades in SYK, 63% of them bullish and 38% bearish. In the past 30 days there were 31 dark pool prints totaling $31.5M, the largest $2.4M.

AI Auto Pilots
Is SYK in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$26.3B
+7.9% vs a year ago
Net income
$3.6B
+23.1% vs a year ago
EPS (diluted)
$9.39
+23.4% vs a year ago
Free cash flow
$4.6B
17.4% margin
Valuation
Market cap
$121B
380.7M shares
P/E
33.8
Price over 12 month EPS
Price to sales
4.6
Market cap over revenue
Dividend yield
1.11%
$3.52 a share over 12 months
Balance sheet
Cash & equivalents
$3.3B
At Sep 30
Debt
$14.9B
At Sep 30
Shares outstanding
380.7M
At Sep 30
CEOKevin A. Lobo
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $17.1B$17.1BFY2021FY2022: $18.4B$18.4BFY2022FY2023: $20.5B$20.5BFY2023FY2024: $22.6B$22.6BFY2024FY2025: $25.1B$25.1BFY2025

From SYK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 4
2027 · Time not announced
Consensus EPS forecast
$5.03
$7.70B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 14 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
14firms
11 Buy3 Hold0 Sell
Each firm's latest rating on SYK in the past 90 days
Average 12-month target
$334.71
▲ 5.4% upside

Based on 14 analysts who set a price target on SYK in the past 90 days. The average target is $334.71, with a high of $390.00 and a low of $290.00, compared with the last close of $317.60.

Low $290.00Avg $334.71High $390.00
Blue marker: last close $317.60
Highest target$390.00
Average target$334.71
Lowest target$290.00
Latest rating changes
Piper SandlerTarget lowered
Nov 9Buy$390 → $350
Truist SecuritiesTarget lowered
Nov 2Hold$310 → $305
StifelTarget lowered
Nov 2Buy$330 → $325
JP MorganTarget lowered
Oct 31Buy$350 → $340
CitigroupTarget lowered
Oct 30Buy$360 → $315
DateFirmActionRatingPrice target
Nov 9Piper SandlerTarget loweredBuy$390 → $350
Nov 2Truist SecuritiesTarget loweredHold$310 → $305
Nov 2StifelTarget loweredBuy$330 → $325
Oct 31JP MorganTarget loweredBuy$350 → $340
Oct 30CitigroupTarget loweredBuy$360 → $315
Loading…

Technical Analysis

SYK · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 1% above its 20 day and 8% above its 50 day average. It is 1% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 56). The nearest support is the Pivot at $314.98, and the nearest resistance the 200 day average at $321.38.

Short trendBullish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.4%/day
Key levels
$389.3352 week high+22.6%
$322.87Swing high (May 20)+1.7%
$321.95Pivot R1+1.4%
$321.38200 day average+1.2%
$317.60Last close
$314.98Pivot−0.8%
$313.2020 day average−1.4%
$310.62Pivot S1−2.2%
$310.50100 day average−2.2%
$307.49Swing low (Jul 2)−3.2%
$293.2250 day average−7.7%
$267.0052 week low−15.9%
Indicators
RSI (14)55.58Middle of its rangeNeutral
MACD5.91Below its signal lineBearish
Stochastic45.2Middle of its rangeNeutral
ADX (14)14.2No clear trend
Williams %R-47.4Oversold below −80, overbought above −20Neutral
CCI (20)15.9Oversold below −100, overbought above 100Neutral
Rate of change+2.3%Change over 10 sessionsBullish
ATR (14)$10.65Typical daily range, 3.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for SYK

What happened before

See how SYK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish5 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow SYK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How SYK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
8
Bullish
5
63%
Bearish
3
38%
Date span
Aug 25 – Nov 9
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
31
Notional
$31.5M
Largest print
$2.4M
Loading…

SYK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼897 buying vs 1,134 selling
  • ▼Held by funds -3.1 pts
  • ▼Funds holding -104
  • ▼Superinvestors: 1 added, 4 cut
  • ▲Put/call 0.70 to 0.59
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,1642,268−4.6%
In funds' top 103537−5.4%
Held by funds78.7%81.9%−3.1 pts
New / increased134 / 763139 / 913−14.7%
Reduced / sold out930 / 204854 / 183+9.4%
Put/call ratio0.590.70−15.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SYK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SYK Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$33.0M
0.0% of value
Shares outstanding, 12 months
−0.5%
Fewer shares
Last quarter
$1.0B
Sep 2026
Avg price paid, last quarter
$334.27
3.0M shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $1.0B
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $1.0B, average price $334.27
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SYK is in one of them and how their past SYK trades turned out.

SYK in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SYK in an article yet. Here's the latest on the wider market.

SYK Congress Trades

All congress trades →
Trades, 12 months
38
Buys
18
47%
Sells
20
53%
People
6
Last filed Nov 9
Who traded SYK · since 2016
Latest 5 filings of 158
$1K – $15KTraded Oct 7, 2026Filed Nov 9, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
Thomas KeanSell (partial)
$1K – $15KTraded Sep 30, 2026Filed Oct 30, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
$15K – $50KTraded Sep 11, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 9, 202633 d
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Thomas KeanR · NJSell (partial)$1K – $15KSep 30, 2026Oct 30, 202630 d
Ro KhannaD · CASell$1K – $15KSep 25, 2026Oct 7, 202612 d
Ro KhannaD · CASell$15K – $50KSep 11, 2026Oct 7, 202626 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Stryker

Stryker makes medical technology used in surgery, emergency care and patient care. Its products include surgical equipment and navigation systems, endoscopy and communications systems, patient handling and emergency medical equipment, and implants for hip, knee and shoulder joint replacement. It also sells treatments for stroke and blood clots, along with the Mako robotic-arm system used in orthopaedic surgery. Most products are sold directly to doctors, hospitals and other healthcare facilities. The company is based in Portage, Michigan.

Headquarters
Portage, MI
Founded
1946